Morphine, opioids, and the feline pulmonary vascular bed

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 7, 2008, Pages 931-937

  Kaye, A D ^a   Hoover, J M ^b   Kaye, A J ^a   Ibrahim, I N ^a   Fox, C ^c   Bajwa, A ^a   Anwar, M ^d   Fields, A M ^a   Baluch, A ^e   Huffman, S ^a   Chilian, W ^f  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Fentanyl; Histamine receptor; Lung; Meperidine; Morphine; Opioid receptor; Remifentanil; Sufentanil; Vasodepressor

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BRADYKININ; DIPHENHYDRAMINE; FENTANYL; GLIBENCLAMIDE; HISTAMINE; HISTAMINE RECEPTOR; MORPHINE; NALOXONE; NIMESULIDE; OPIATE; OPIATE RECEPTOR; ORNITHINE; PETHIDINE; PINACIDIL; REMIFENTANIL; SUFENTANIL;

ANIMAL EXPERIMENT; ARTERY PERFUSION; ARTICLE; CAT; DRUG EFFECT; DRUG POTENCY; FEMALE; LUNG BLOOD VESSEL; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; VASODILATATION;

ANALGESICS, OPIOID; ANIMALS; BLOOD PRESSURE; CATS; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; FENTANYL; GLYBURIDE; LUNG; MALE; MEPERIDINE; MORPHINE; NALOXONE; ORNITHINE; PIPERIDINES; PROSPECTIVE STUDIES; PULMONARY ARTERY; PULMONARY CIRCULATION; SUFENTANIL; SULFONAMIDES; VASODILATION; VASODILATOR AGENTS;

EID: 46749130095     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01595.x     Document Type: Article

References (16)

1. Reisine T, Pasternak G. Opioid analgesics and antagonists. In : Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman's the pharmacological basis of therapeutics, 10th edn. New York : McGraw-Hill, 2001 : 357, 569 95.
2. Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem 2004 73 : 953 90.
3. Goodsell DS. The molecular perspective: morphine. Oncologist 2004 9 (6) : 717 8.
4. Fioramonti J, Bueno L. Centrally acting agents and visceral sensitivity. Gut 2002 51 (Suppl. 1) : i91 5.
5. Tanobe K, Nishikawa K, Hinohara H et al. Blood-brain barrier and general anesthetics. Masui 2003 52 (8) : 840 5.
6. Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil 2004 16 (Suppl. 2) : 17 28.
7. Rosow CE, Moss J, Philbin DM et al. Histamine release during morphine and fentanyl anesthesia. Anesthesiology 1982 56 (2) : 93 6.
8. Kaye AD, Baluch A, Phelphs J et al. An analysis of remifentanil in the pulmonary vascular bed of the cat. Anesth Analg 2006 102 (1) : 118 23.
9. Kaye AD, Hoover JM, Baber SR et al. The effects of meperidine in the pulmonary vascular bed of the cat. J Cardiothorac Vasc Anesth 2006 20 (5) : 691 5.
10. Kaye AD, Hoover JM, Ibrahim IN et al. Analysis of the effects of fentanyl in the feline pulmonary vascular bed. Am J Ther 2006 13 (6) : 478 84.
11. Kaye AD, Phelps J, Baluch A et al. The effects of sufentanil in the feline pulmonary vascular bed. Eur J Pharmacol 2006 534 (1-3) : 159 64.
12. Sahin N, Ozdem S, Sadan G. The effect of nitric oxide synthase blockade on responses to morphine in rat aortic rings. Auton Autacoid Pharmacol 2002 22 (2) : 103 7.
13. Brill S, Gurman GM, Fisher A. A history of neuraxial administration of local analgesics and opioids. Eur J Anaesthesiol 2003 20 (9) : 682 9.
14. Snedecor GW, Cochran WG. Statistical methods, 6th edn. Ames, IA : Iowa State University Press, 1967 : 258 338.
15. Inan S, Tallarida RJ. Morphine potentiates dextromethorphan-induced vasodilation in rat superior mesenteric artery. Eur J Pharmacol 2004 486 (1) : 61 5.
16. Tuncer S, Bariskaner H, Dogan N. The relaxant effects of alfentanil and remifentanil on noradrenaline-treated rat aorta. Pain Clinic 2003 15 (3) : 321 5.